Muralidhar Bali (CIK 0001784138)

Latest company ownership

XCUR - EXICURE, INC.
Role: Director
Shares held
50,000
Last filed at
Jun 15, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
Shares held
30,000
Last filed at
May 24, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
17,500
Last filed at
Jun 8, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 19, 2022 May 19, 2022 EXICURE, INC. Director Buy 97.5 +1,472,126 21.10% ✗ $285.2K
Jul 14, 2021 Jul 15, 2021 OnKure Therapeutics, Inc. Director Buy 92.5 +111,736 5.69% ✗ $949.8K
Jun 23, 2021 Jun 25, 2021 OnKure Therapeutics, Inc. Director Buy 82.5 +20,710 1.07% ✗ $192.2K
Jun 21, 2021 Jun 23, 2021 OnKure Therapeutics, Inc. Director Buy 85.0 +47,274 2.50% ✗ $422.4K
Jun 8, 2021 Jun 10, 2021 OnKure Therapeutics, Inc. Director Buy 72.5 +16,605 0.88% ✗ $157.7K
Jun 3, 2021 Jun 7, 2021 OnKure Therapeutics, Inc. Director Buy 72.5 +12,357 0.66% ✗ $114.4K
May 28, 2021 Jun 2, 2021 OnKure Therapeutics, Inc. Director Buy 47.5 +14 0.00% ✗ $133
May 26, 2021 May 28, 2021 OnKure Therapeutics, Inc. Director Buy 65.0 +7,035 0.38% ✗ $65.9K
Apr 13, 2021 Apr 15, 2021 OnKure Therapeutics, Inc. Director Buy 100.0 +200,000 12.06% ✗ $3M
Oct 14, 2020 Oct 16, 2020 SPRUCE BIOSCIENCES, INC. Director Buy 100.0 +200,000 12.56% ✗ $3M
Dec 19, 2019 Dec 23, 2019 EXICURE, INC. Director Buy 100.0 +727,000 11.63% ✗ $2M